Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perou

Showing results (211-220 of 476) with videos related to

Pageof 48
Sort By:
Clinical Breast Cancer|August 31, 2024
A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast CancerDanielle M File, Yara Abdou, Jeremy Force, et al.
Breast Cancer Research : BCR|March 22, 2024
BIRC5 expression by race, age and clinical factors in breast cancer patientsAlina M Hamilton, Andrea Walens, Sarah C Van Alsten, et al.
Histopathology|September 19, 2006
Cytokeratin profiles of male breast cancersV Ciocca, A Bombonati, Z Gatalica, et al.
Breast Cancer Research and Treatment|November 13, 2013
Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancerSneha Sundaram, Alex J Freemerman, Amy R Johnson, et al.
The Journal of Clinical Investigation|January 18, 2017
Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formationDaniel O Kechele, R Eric Blue, Bailey Zwarycz, et al.
Cancer Research Communications|March 2, 2023
Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals <i>TP53</i> Aneuploidy-driven Metabolic ReprogrammingMarni B McClure, Yasunori Kogure, Naser Ansari-Pour, et al.
Nano Today|July 24, 2023
High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast CancerChaemin Lim, Duhyeong Hwang, Mostafa Yazdimamaghani, et al.
Cancer Research|May 27, 2010
Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancerAdam C Pond, Jason I Herschkowitz, Kathryn L Schwertfeger, et al.
Journal for Immunotherapy of Cancer|May 27, 2025
B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancerSimone Stucchi, Roberto Borea, Susana Garcia-Recio, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Maintenance of hormone responsiveness in luminal breast cancers by suppression of NotchJames M Haughian, Mauricio P Pinto, J Chuck Harrell, et al.
Pageof 48

Showing results (211-220 of 476) with videos related to

Sort By:
Pageof 48
Clinical Breast Cancer|August 31, 2024
A Phase I Trial of Alpelisib Combined With Capecitabine in Patients With HER2-Negative Metastatic Breast CancerDanielle M File, Yara Abdou, Jeremy Force, et al.
Breast Cancer Research : BCR|March 22, 2024
BIRC5 expression by race, age and clinical factors in breast cancer patientsAlina M Hamilton, Andrea Walens, Sarah C Van Alsten, et al.
Histopathology|September 19, 2006
Cytokeratin profiles of male breast cancersV Ciocca, A Bombonati, Z Gatalica, et al.
Breast Cancer Research and Treatment|November 13, 2013
Role of HGF in obesity-associated tumorigenesis: C3(1)-TAg mice as a model for human basal-like breast cancerSneha Sundaram, Alex J Freemerman, Amy R Johnson, et al.
The Journal of Clinical Investigation|January 18, 2017
Orphan Gpr182 suppresses ERK-mediated intestinal proliferation during regeneration and adenoma formationDaniel O Kechele, R Eric Blue, Bailey Zwarycz, et al.
Cancer Research Communications|March 2, 2023
Landscape of Genetic Alterations Underlying Hallmark Signature Changes in Cancer Reveals <i>TP53</i> Aneuploidy-driven Metabolic ReprogrammingMarni B McClure, Yasunori Kogure, Naser Ansari-Pour, et al.
Nano Today|July 24, 2023
High-Dose Paclitaxel and its Combination with CSF1R Inhibitor in Polymeric Micelles for Chemoimmunotherapy of Triple Negative Breast CancerChaemin Lim, Duhyeong Hwang, Mostafa Yazdimamaghani, et al.
Cancer Research|May 27, 2010
Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancerAdam C Pond, Jason I Herschkowitz, Kathryn L Schwertfeger, et al.
Journal for Immunotherapy of Cancer|May 27, 2025
B7-H3 and CSPG4 co-targeting as Pan-CAR-T cell treatment of triple-negative breast cancerSimone Stucchi, Roberto Borea, Susana Garcia-Recio, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Maintenance of hormone responsiveness in luminal breast cancers by suppression of NotchJames M Haughian, Mauricio P Pinto, J Chuck Harrell, et al.
Pageof 48